ArticleFrontiers in plant science2022
Deep Learning-Based Segmentation of Peach Diseases Using Convolutional Neural Network.
Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 32 citations in OpenAlex.
- You only look once-based neural network and grading method for peach leaf shot hole disease detection under natural conditions.Frontiers in plant science · 2026Article
- Deep learning-based automatic tree-level crown detection from high-resolution UAV imagery for aboveground carbon stock estimation.Frontiers in plant science · 2026Article
- Application of Mask R-CNN for automatic recognition of teeth and caries in cone-beam computerized tomography.BMC oral health · 2025Article
- Semantic segmentation of microbial alterations based on SegFormer.Frontiers in plant science · 2024Article
- CSXAI: a lightweight 2D CNN-SVM model for detection and classification of various crop diseases with explainable AI visualization.Frontiers in plant science · 2024Article
- TP-Transfiner: high-quality segmentation network for tea pest.Frontiers in plant science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peach diseases seriously affect peach yield and people's health. The precise identification of peach diseases and the segmentation of the diseased areas can provide the basis for disease control and treatment. However, the complex background and imbalanced samples bring certain challenges to the segmentation and recognition of lesion area, and the hard samples and imbalance samples can lead to a decline in classification of foreground class and background class. In this paper we applied deep network models (Mask R-CNN and Mask Scoring R-CNN) for segmentation and recognition of peach diseases. Mask R-CNN and Mask Scoring R-CNN are classic instance segmentation models. Using instance segmentation model can obtain the disease names, disease location and disease segmentation, and the foreground area is the basic feature for next segmentation. Focal Loss can solve the problems caused by difficult samples and imbalance samples, and was used for this dataset to improve segmentation accuracy. Experimental results show that Mask Scoring R-CNN with Focal Loss function can improve recognition rate and segmentation accuracy comparing to Mask Scoring R-CNN with CE loss or comparing to Mask R-CNN. When ResNet50 is used as the backbone network based on Mask R-CNN, the segmentation accuracy of segm_mAP_50 increased from 0.236 to 0.254. When ResNetx101 is used as the backbone network, the segmentation accuracy of segm_mAP_50 increased from 0.452 to 0.463. In summary, this paper used Focal Loss on Mask R-CNN and Mask Scoring R-CNN to generate better mAP of segmentation and output more detailed information about peach diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.